Increased matrix concentrations of IGFBP-5 in cancellous bone in osteoarthritis

Ann Rheum Dis. 2004 Sep;63(9):1162-5. doi: 10.1136/ard.2003.013920.

Abstract

Background: In osteoarthritis cancellous bone adapts to meet altered mechanical loading. These changes may be mediated by insulin-like growth factors (IGF-I and IGF-II), but the matrix bound binding protein, IGFBP-5 has not been investigated.

Objectives: To measure IGF-I, IGF-II, and IGFBP-5 in femoral head bone from non-OA controls and patients with OA, and to relate these to apparent density (rhoA) and elastic modulus (Ec).

Methods: rhoA, Ec, and IGF system components were measured in cancellous bone from superior and inferior regions of femoral heads from 31 patients with OA and 11 age selected controls.

Results: Ec and rhoA were greater (p<0.05) in the superior region of all femoral heads. In primary OA, rhoA was increased in the inferior region (p<0.05). IGFBP-5 was increased, about twofold, at superior and inferior regions in primary OA (1.60 and 1.54 ng/mg bone, respectively, both p<0.05) and in Paget's disease (2.44 and 1.75 ng/mg bone, both p<0.05) compared with controls (0.73 and 0.95 ng/mg bone). In controls, inverse correlations between IGFBP-5 and both rhoA and Ec at superior (rs = -0.64 and -0.73, both p<0.05) and inferior regions (rs = -0.72, p<0.05 and -0.24 (NS)) were seen, but these were lost in OA.

Conclusions: IGFBP-5 may modulate cancellous bone formation by negative feedback. In end stage OA this is disrupted, but has little influence on material properties.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bone Density
  • Compressive Strength
  • Female
  • Femur Head / chemistry
  • Humans
  • Insulin-Like Growth Factor Binding Protein 5 / analysis*
  • Insulin-Like Growth Factor I / analysis
  • Insulin-Like Growth Factor II / analysis
  • Male
  • Middle Aged
  • Osteoarthritis, Hip / metabolism*
  • Osteoarthritis, Hip / physiopathology

Substances

  • Insulin-Like Growth Factor Binding Protein 5
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II